Time Line

  • 2015 Primate testing began in May.
  • 2015 Seeking funding and alliances for additional testing, purification of compound, and finalization of pending patents.
  • 2015 Compound potentially removes SHIV/SIV upon contact.
  • 2014 University tested compound in-vitro and validated the compound could potentially restore the immune system.
  • 2013 Introduced to a reputable university to test in-vitro, determine the mechanism of action, chemical composition, and the anti-viral ingredient.
  • 2012 Searched for a reputable institution to test compound in-vitro.
  • 2010 Clinical testing on humans subjects begins in Monrovia, Liberia, West Africa.
  • 2010 Two patents applications were filed.
  • 2010 BNEERS was created.
  • 2010 Obtained legal representation.
  • 2008 The technology was taken to Monrovia, Liberia, West Africa.
  • 2003 More members were added to help market the compound.
  • 1999 Begin to introduce the compound and its capabilities to doctors, medical research centers, higher education institutions, and other individuals to no avail.
  • 1998 Spread the word about the capabilities of the compound.
  • 1998 Developed a unique compound that exhibits exceptional characteristics that could potentially restore the immune system.